Lantern Pharma, Inc. (LTRN)

2.20 +0.23 (+11.68%) USD  |  NASDAQ  |  Apr 13, 16:00
2.15 -0.05 (-2.27%) After-Hours: 16:42
More

Lantern Pharma Price to Book Value (3y Mean)

Price to Book Value (3y Mean) Chart

View Price to Book Value (3y Mean) for LTRN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to Book Value (3y Mean) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to Book Value (3y Mean) Range, Past 5 Years

View Price to Book Value (3y Mean) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to Book Value (3y Mean) Benchmarks

View Price to Book Value (3y Mean) Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
BioVie, Inc. Upgrade
Acurx Pharmaceuticals, Inc. Upgrade
ACADIA Pharmaceuticals, Inc. Upgrade
Alnylam Pharmaceuticals, Inc. --